SANUWAVE Health, Inc. (OTCBB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 8,088,073, titled "Device for the Application of Acoustic Shock Waves."
The patent has a term extending to June 2025 and is directed to an invention for an electrohydraulic shock wave device having novel features that may enhance the capabilities of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology platform. This patented invention for delivering shock waves into living tissue includes a multi-adjustable reflector contained within a tissue-contacting treatment applicator that allows adjusting the positions where shock waves are generated and delivered into the body with modifiable tissue penetration depths. The patent also offers the improvement of a fastening or "pivot" point within the applicator's housing to enable the reflector to tilt in any direction, thus increasing the volume of tissue treated from a single applicator position.
"We are delighted to add this patent to our growing intellectual property portfolio, which will extend and consolidate our leadership position in the use of PACE technology for tissue regeneration," stated Christopher M. Cashman, President and CEO of SANUWAVE. "This patent protects the capability of our proprietary technology and has the potential to expand our treatment options, including the ability to target a wider variety of tissues in the pursuit of new clinical applications."